Mildly enhanced coagulation during CRS induced by suppressed fibrinolysis and corresponding enhanced fibrin degradation at the end of CRS. Fluctuation in coagulation markers is shown in TAT (A), AT (B), and soluble fibrin (C). Enhanced fibrin degradation is also indicated using FDP (D), d-dimer (E), and E-XDP (F). *P < .05; **P < .01. ns, not significant.